RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease - read this article along with other careers information, tips and advice on BioSpace
USPTO grants new method of use patent for the inhibition of a disease caused by a coronavirus in patients having pneumonia and receiving supplemental oxygen at.
/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the granting of U.S..
RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034The patent is directed to the Talicia® formulation and pharmaceutical kits for use in the treatment of H.
RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.